A Protein-Truncating <i>HSD17B13</i> Variant and Protection from Chronic Liver Disease

A loss-of-function variant in HSD17B13 was associated with a reduced risk of chronic liver disease and of progression from steatosis to steatohepatitis. (Funded by Regeneron Pharmaceuticals and others.).